Ocuphire Pharma, Inc. vs Aardvark Therapeutics, Inc., risk disclosures compared

0topics both disclose

9only Ocuphire Pharma, Inc.

6only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Ocuphire Pharma, Inc.	Aardvark Therapeutics, Inc.
Nothing in common

Only Ocuphire Pharma, Inc.

Topic	Filings
Enforcement Action	6
Internal Control	6
Material Weakness	5
Consent Order	4
Restatement	4
Third Party Risk Management	3
Artificial Intelligence	2
Data Breach	1
Whistleblower Program	1

Only Aardvark Therapeutics, Inc.

Topic	Filings
Business Continuity	7
Ransomware	4
Cross Border Data Transfer	3
Data Residency	3
Audit Committee Oversight	2
ESG Reporting	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Ocuphire Pharma, Inc. · Aardvark Therapeutics, Inc. · All companies